Andreas Halvorsen's Viking Global Investors initiated a new stake in CVS Health Corp. during the second quarter of 2026, according to a recent SEC disclosure. The investment firm purchased 3.66 million shares, valued at approximately $378.97 million as of the end of the reporting period. This new position accounts for about 1.08% of Viking's reported public equity portfolio.
This trade information comes from a mandatory 13F filing, which discloses positions held as of June 30, 2026. These filings are released with a delay and may not reflect the firm's current holdings. The investment came during a quarter where CVS reported strong financial results, raising its full-year earnings guidance after seeing revenues increase by 7.3% year-over-year to $106.1 billion.